Zsuzsanna Gaborik

Charles River Laboratories Hungary
Budapest, BU 1117, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Ginger and Its Purified Major Components Inhibit Clinically Relevant Uptake and Efflux Transporters In Vitro.

Ginger and Its Purified Major Components Inhibit Clinically Relevant Uptake and Efflux Transporters In Vitro.

Journal: Pharmaceutics

Published: November 28, 2025

Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A.

Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A.

Journal: Pharmaceutics

Published: October 08, 2025

Expression and function of CYP enzymes and hepatobiliary transporters in an improved long-term sandwich culture hepatocyte model.

Expression and function of CYP enzymes and hepatobiliary transporters in an improved long-term sandwich culture hepatocyte model.

Journal: Scientific reports

Published: May 29, 2025

Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?

Are Δ9-Tetrahydrocannabinol and Its Major Metabolites Substrates or Inhibitors of Placental or Human Hepatic Drug Solute-Carrier Transporters?

Journal: International journal of molecular sciences

Published: October 31, 2024

Modulation of Multispecific Transporters by Uncaria tomentosa Extract and Its Major Phytoconstituents.

Modulation of Multispecific Transporters by Uncaria tomentosa Extract and Its Major Phytoconstituents.

Journal: Pharmaceutics

Published: September 10, 2024

Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction.

Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction.

Journal: Pharmaceutics

Published: April 30, 2024

Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC).

Identification of reversible OATP1B1 and time-dependent CYP3A4 inhibition as the major risk factors for drug-induced cholestasis (DIC).

Journal: Archives of toxicology

Published: September 28, 2023

Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics-Informed Relative Expression Factor Approach.

Successful Prediction of Human Hepatic Concentrations of Transported Drugs Using the Proteomics-Informed Relative Expression Factor Approach.

Journal: Clinical pharmacology and therapeutics

Published: September 01, 2023

Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters.

Interactions of the Anti-SARS-CoV-2 Agents Molnupiravir and Nirmatrelvir/Paxlovid with Human Drug Transporters.

Journal: International journal of molecular sciences

Published: June 04, 2023

A Unique In Vitro Assay to Investigate ABCB4 Transport Function.

A Unique In Vitro Assay to Investigate ABCB4 Transport Function.

Journal: International journal of molecular sciences

Published: January 13, 2023

The Inhibitor Preincubation Effect Is Universal to SLC Transporter Assays and Is Only Partially Eliminated in the Presence of Extracellular Protein.

The Inhibitor Preincubation Effect Is Universal to SLC Transporter Assays and Is Only Partially Eliminated in the Presence of Extracellular Protein.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: October 30, 2022

Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk.

Translatability of in vitro Inhibition Potency to in vivo P-Glycoprotein Mediated Drug Interaction Risk.

Journal: Journal of pharmaceutical sciences

Published: October 16, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026